SenolyticEmerging

Fisetin

Flavonoid with senolytic activity in animal models. Clinical endpoints in humans still unclear.

Also known as: 3,3',4',7-tetrahydroxyflavone

Goals
Longevity (broad)
Timing
Pulse dosed
Price tier
Premium

Dosage

Study protocols: 20 mg/kg on 2 consecutive days per month. Liposomal form preferred for bioavailability.

Considerations

Mayo Clinic trials ongoing. Until then: experimental, not standard practice.

VeganDrug interactionsNot during pregnancy
Form
Capsule

Scientific detail

Mechanisms
Senolytische ClearanceAnti-InflammatorischPI3K/AKT-Inhibition
Hallmarks of aging
Cellular senescenceChronic inflammation
Evidence base

Studies on Fisetin

1,572 studies total · Open on PubMed

View all studies

Where to buy

Affiliate link — we may earn a commission at no extra cost to you.